BioSpace News Archive

Pharm Country

FUJIFILM Diosynth Biotechnologies and NeuExcell Therapeutics enter manufacturing agreement to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke

The signing of the manufacturing agreement with NeuExcell showcases our flexibility in supporting biotech companies of all sizes, and our focused commitment to enabling NeuExcell to reach the full potential of their innovative gene technology platform on accelerated timelines.

September 13, 2021
·
2 min read
Business

Alzheon Appoints Adem Albayrak as Head of Operations and Earvin Liang, PhD, as Vice President of Clinical Development

Alzheon, Inc. announced the appointment of Adem Albayrak as Head of Operations, and Earvin Liang, PhD, as Vice President of Clinical Development.

September 13, 2021
·
9 min read
Business

Lucence Presents Data at ESMO 2021 Showing Liquid Biopsy Detects Actionable Genomic Alterations in Bladder Cancer Patients Undergoing Immunotherapy

Precision oncology company Lucence, in collaboration with researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, is sharing data highlighting the capabilities of its amplicon-based liquid biopsy technology to detect and characterize genomic alterations in ctDNA in patients with late-stage bladder cancer undergoing immunotherapy.

September 13, 2021
·
3 min read
Drug Development

MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced top-line results from two late-stage musculoskeletal clinical trials of the Company’s micronized dehydrated Human Amnion Chorion Membrane (mdHACM): a Phase 2B clinical trial for the treatment of Knee Osteoarthritis (KOA) and a Phase 3 clinical trial for the treatment of Plantar Fasciitis (PF).

September 13, 2021
·
11 min read
Audiological Devices Market Size to Grow Exponentially during the Assessment Period

The global audiological devices market is foreseen to expand at a CAGR of 5.0% and gather the valuation of US$ 13.4 Bn by the end of forecast period 2018–2026, opines a new research report by TMR.

September 13, 2021
·
5 min read
Telehealth Market Size to Expand Lucratively during the Forecast Period

Transparency Market Research has published a new report titled, “Telehealth Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

September 13, 2021
·
6 min read
Drug Development

Boehringer Ingelheim and OSE Immunotherapeutics to Present Phase 1 Results with First-in-Class SIRPα Inhibitor BI 765063 in Advanced Solid Tumors at ESMO 2021

OSE Immunotherapeutics SA announced that promising data from dose escalation Phase 1 of selective SIRPα inhibitor BI 765063 in patients with advanced solid tumors will be presented at the 2021 European Society for Medical Oncology Virtual Conference to be held on September 16 – 21, 2021.

September 13, 2021
·
7 min read
Drug Development

Harbour BioMed Announces Phase I Study Positive Results on Next-Generation Anti-CTLA-4 Antibody HBM4003

Harbour BioMed announced positive results from its phase I dose escalation clinical trial of HBM4003 in solid tumors in Australia.

September 13, 2021
·
3 min read
Deals

ZOLL Medical Corporation Signs Definitive Agreement to Acquire Itamar Medical

ZOLL® Medical Corporation and Itamar™ Medical Ltd. announced that the two companies signed a definitive agreement under which ZOLL Medical will acquire all outstanding ordinary shares of Itamar Medical for a total value of approximately $538 million.

September 13, 2021
·
9 min read
Providence Therapeutics Reports PTX-COVID19-B, its mRNA Vaccine for COVID-19, Neutralizes SARS-CoV-2 and Variants of Concern, Including Delta

Providence Therapeutics announced additional results from its Phase 1 study, PRO-CL-001, of PTX-COVID19-B.

September 13, 2021
·
5 min read